BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michail G, Labrou M, Pitiriga V, Manousaka S, Sakellaridis N, Tsakris A, Pournaras S. Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model. Antimicrob Agents Chemother 2013;57:6028-33. [PMID: 24060874 DOI: 10.1128/AAC.00891-13] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother 2014;58:3541-6. [PMID: 24687491 DOI: 10.1128/AAC.02449-14] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
2 Oh S, Chau R, Nguyen AT, Lenhard JR. Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens? Antibiotics (Basel) 2021;10:646. [PMID: 34071451 DOI: 10.3390/antibiotics10060646] [Reference Citation Analysis]
3 Pitout JD, Nordmann P, Poirel L. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother 2015;59:5873-84. [PMID: 26169401 DOI: 10.1128/AAC.01019-15] [Cited by in Crossref: 380] [Cited by in F6Publishing: 227] [Article Influence: 54.3] [Reference Citation Analysis]
4 Lee H, Lee D. Carbapenem-resistant Enterobacteriaceae : recent updates and treatment strategies. J Korean Med Assoc 2018;61:281. [DOI: 10.5124/jkma.2018.61.4.281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
5 Gaibani P, Lombardo D, Bartoletti M, Ambretti S, Campoli C, Giannella M, Tedeschi S, Conti M, Mancini R, Landini MP, Re MC, Viale P, Lewis RE. Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 2019;38:1925-31. [PMID: 31278562 DOI: 10.1007/s10096-019-03628-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Bergen PJ, Bulman ZP, Landersdorfer CB, Smith N, Lenhard JR, Bulitta JB, Nation RL, Li J, Tsuji BT. Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria. Infect Dis Ther 2015;4:391-415. [PMID: 26645096 DOI: 10.1007/s40121-015-0093-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
7 Choi S, Moon SM, Park SJ, Lee SC, Jung KH, Sung HS, Kim MN, Jung J, Kim MJ, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS, Chong YP. Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in In Vitro and In Vivo Studies. Antimicrob Agents Chemother 2020;64:e01925-19. [PMID: 32041713 DOI: 10.1128/AAC.01925-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Rechenchoski DZ, Dambrozio AML, Vivan ACP, Schuroff PA, Burgos TDN, Pelisson M, Perugini MRE, Vespero EC. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates. Braz J Microbiol 2017;48:509-14. [PMID: 28552659 DOI: 10.1016/j.bjm.2017.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Amin M, Navidifar T, Shooshtari FS, Rashno M, Savari M, Jahangirmehr F, Arshadi M. Association Between Biofilm Formation, Structure, and the Expression Levels of Genes Related to biofilm formation and Biofilm-Specific Resistance of Acinetobacter baumannii Strains Isolated from Burn Infection in Ahvaz, Iran. Infect Drug Resist 2019;12:3867-81. [PMID: 31853190 DOI: 10.2147/IDR.S228981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
10 Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 2015;36:74-84. [PMID: 25643272 DOI: 10.1055/s-0035-1544208] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 17.6] [Reference Citation Analysis]
11 Fan B, Guan J, Wang X, Cong Y. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. PLoS One 2016;11:e0157757. [PMID: 27315107 DOI: 10.1371/journal.pone.0157757] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
12 Toledo PV, Aranha Junior AA, Arend LN, Ribeiro V, Zavascki AP, Tuon FF. Activity of antimicrobial combinations against KPC-2-producing Klebsiella pneumoniae in a rat model and time-kill assay. Antimicrob Agents Chemother 2015;59:4301-4. [PMID: 25896686 DOI: 10.1128/AAC.00323-15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
13 Lenhard JR, Nation RL, Tsuji BT. Synergistic combinations of polymyxins. Int J Antimicrob Agents 2016;48:607-13. [PMID: 27865626 DOI: 10.1016/j.ijantimicag.2016.09.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
14 Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Rev 2018;31:e00079-17. [PMID: 29444952 DOI: 10.1128/CMR.00079-17] [Cited by in Crossref: 241] [Cited by in F6Publishing: 132] [Article Influence: 60.3] [Reference Citation Analysis]
15 Machuca I, Gutiérrez-Gutiérrez B, Gracia-Ahufinger I, Rivera Espinar F, Cano Á, Guzmán-Puche J, Pérez-Nadales E, Natera C, Rodríguez M, León R, Castón JJ, Rodríguez-López F, Rodríguez-Baño J, Torre-Cisneros J. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems. Antimicrob Agents Chemother 2017;61:e00406-17. [PMID: 28559247 DOI: 10.1128/AAC.00406-17] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 7.2] [Reference Citation Analysis]
16 Zheng JX, Lin ZW, Chen C, Chen Z, Lin FJ, Wu Y, Yang SY, Sun X, Yao WM, Li DY, Yu ZJ, Jin JL, Qu D, Deng QW. Biofilm Formation in Klebsiella pneumoniae Bacteremia Strains Was Found to be Associated with CC23 and the Presence of wcaG. Front Cell Infect Microbiol 2018;8:21. [PMID: 29527517 DOI: 10.3389/fcimb.2018.00021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
17 Bi S, Yao X, Huang C, Zheng X, Xuan T, Sheng J, Xu K, Zheng B, Yang Q. Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection. Infection 2019;47:497-500. [PMID: 30734249 DOI: 10.1007/s15010-019-01274-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Chen F, Wei MC, Luo YD, Jin Z, Tang YZ. Synergistic Effect of a Pleuromutilin Derivative with Tetracycline against Streptococcus suis In Vitro and in the Neutropenic Thigh Infection Model. Molecules 2020;25:E3522. [PMID: 32752180 DOI: 10.3390/molecules25153522] [Reference Citation Analysis]
19 Zhang Y, Li P, Yin Y, Li F, Zhang Q. In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates. J Antibiot (Tokyo) 2017;70:193-5. [PMID: 27460764 DOI: 10.1038/ja.2016.93] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]